Clinical Pathology Associates (CPA), a trusted leader in anatomic and clinical pathology services since 1948, today announced its rebrand to Oculus Pathology, marking a significant evolution in the organization’s identity. This change reflects the company’s steadfast commitment to precision, partnership, and innovation, while also charting a course for the future of specialty pathology.
The name “Oculus”, derived from the Latin word for “window,” symbolizes the company’s core purpose: to provide unparalleled clarity and insight into patient health. It also highlights its role as a trusted partner with other specialty physicians and providers, enabling them to deliver exceptional outcomes through precision diagnostics, expert consultation, and personalized treatment.
“Rebranding to Oculus Pathology is not just a change in name — it’s a statement about who we are and where we’re headed,” said Matt Thompson, CEO of Oculus Pathology. “The name ‘Oculus’ embodies our mission to provide a clear lens into patient care, while our core values—service, quality, and integrity—remain the foundation of everything we do. With this new identity, we are even better positioned to lead the field of pathology into a future defined by innovation and excellence.”
What is staying the same?
- Our core values: Service, quality, and integrity.
- Our commitment to personalized service, accuracy, and innovation in patient care.
- The team of specialized pathologists, dedicated to delivering best-in-class results for healthcare providers.
- Our state-of-the-art pathology lab accredited by the College of American Pathologists and CLIA-certified.
- Our physician ownership.
What is changing?
- A new name and brand identity designed to stand out in a competitive market.
- A focus on modernization, reflecting advancements in pathology and technology.
- Enhanced communications and outreach, ensuring clarity and accessibility for all stakeholders.
“Oculus Pathology reflects that we are, in many ways, a new and improved practice,” said Edward G. Weir, M.D., president, Board of Directors, Oculus Pathology. “We’ve got a renewed commitment to our mission and our core values and a redefined, strategic vision of the future of healthcare and pathology.”
In conjunction with the rebrand, Oculus Pathology launches a new visual identity that includes a logo inspired by the “window” concept. Interlocking rings within the design symbolize connection, precision, and the collaborative partnerships that define the company’s ethos. The rebrand rollout includes an updated website, enhanced social media presence, and targeted campaigns to ensure a seamless transition for clients and stakeholders.
“While our name and look may have changed, our commitment to our clients remains unwavering,” said Thompson. “Oculus Pathology continues to deliver the trusted expertise and personalized service our clients depend on, with an eye firmly fixed on the future of healthcare.”